SDHA
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
Also known as: FP, SDH2, SDHA_HUMAN, SDHF
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P31040
- Gene
- SDHA
- Ensembl
- ENSG00000073578
- Chromosome
- 5
- Canonical length
- 664 aa
- Protein class
- Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoli,Mitochondria
OverviewNCBI Gene
This gene encodes a major catalytic subunit of succinate-ubiquinone oxidoreductase, a complex of the mitochondrial respiratory chain. The complex is composed of four nuclear-encoded subunits and is localized in the mitochondrial inner membrane. Mutations in this gene have been associated with a form of mitochondrial respiratory chain deficiency known as Leigh Syndrome. A pseudogene has been identified on chromosome 3q29. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2014]
Canonical amino-acid sequenceUniProt
664 residues, UniProt reviewed canonical sequence.
>P31040|SDHA
1 MSGVRGLSRL LSARRLALAK AWPTVLQTGT RGFHFTVDGN KRASAKVSDS ISAQYPVVDH
61 EFDAVVVGAG GAGLRAAFGL SEAGFNTACV TKLFPTRSHT VAAQGGINAA LGNMEEDNWR
121 WHFYDTVKGS DWLGDQDAIH YMTEQAPAAV VELENYGMPF SRTEDGKIYQ RAFGGQSLKF
181 GKGGQAHRCC CVADRTGHSL LHTLYGRSLR YDTSYFVEYF ALDLLMENGE CRGVIALCIE
241 DGSIHRIRAK NTVVATGGYG RTYFSCTSAH TSTGDGTAMI TRAGLPCQDL EFVQFHPTGI
301 YGAGCLITEG CRGEGGILIN SQGERFMERY APVAKDLASR DVVSRSMTLE IREGRGCGPE
361 KDHVYLQLHH LPPEQLATRL PGISETAMIF AGVDVTKEPI PVLPTVHYNM GGIPTNYKGQ
421 VLRHVNGQDQ IVPGLYACGE AACASVHGAN RLGANSLLDL VVFGRACALS IEESCRPGDK
481 VPPIKPNAGE ESVMNLDKLR FADGSIRTSE LRLSMQKSMQ NHAAVFRVGS VLQEGCGKIS
541 KLYGDLKHLK TFDRGMVWNT DLVETLELQN LMLCALQTIY GAEARKESRG AHAREDYKVR
601 IDEYDYSKPI QGQQKKPFEE HWRKHTLSYV DVGTGKVTLE YRPVIDKTLN EADCATVPPA
661 IRSYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SDHA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 522 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 522 nTPM
- skeletal muscle: 447 nTPM
- liver: 258 nTPM
- tongue: 217 nTPM
- choroid plexus: 209 nTPM
- duodenum: 142 nTPM
Single-cell type
- renal collecting duct intercalated cells: 91 nCPM
- distal convoluted tubule cells: 76 nCPM
- renal connecting tubule cells: 76 nCPM
- loop of henle epithelial cells: 63 nCPM
- choroid plexus epithelial cells: 62 nCPM
- proximal tubule cells: 56 nCPM
Immune cell
- T-reg: 149 nTPM
- total PBMC: 110 nTPM
- gdT-cell: 96 nTPM
- memory CD8 T-cell: 94 nTPM
- memory CD4 T-cell: 93 nTPM
- myeloid DC: 93 nTPM
Brain region
- cerebellum: 77 nTPM
- pons: 70 nTPM
- hypothalamus: 66 nTPM
- medulla oblongata: 65 nTPM
- thalamus: 62 nTPM
- cerebral cortex: 52 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SDHA.
Disease | AllUniProt
Conditions SDHA is implicated in, by any mechanism.
- Mitochondrial complex II deficiency, nuclear type 1 (MC2DN1) MIM:252011
- Leigh syndrome (LS) MIM:256000
- Cardiomyopathy, dilated, 1GG (CMD1GG) MIM:613642
- Pheochromocytoma/paraganglioma syndrome 5 (PPGL5) MIM:614165
- Neurodegeneration with ataxia and late-onset optic atrophy (NDAXOA) MIM:619259
Disease | GeneticClinVar
329 pathogenic / likely-pathogenic of 3,314 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pheochromocytoma/paraganglioma syndrome 5
- Mitochondrial complex II deficiency, nuclear type 1
- Hereditary cancer-predisposing syndrome
- Dilated cardiomyopathy 1GG
- Neurodegeneration with ataxia and late-onset optic atrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.74
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mitochondrial electron transport, succinate to ubiquinone
- nervous system development
- proton motive force-driven mitochondrial ATP synthesis
- respiratory electron transport chain
- succinate metabolic process
- tricarboxylic acid cycle
Molecular functions
- electron transfer activity
- flavin adenine dinucleotide binding
- succinate dehydrogenase (quinone) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- FAD/NAD(P)-binding domain superfamily
- Fumarate reductase/succinate dehydrogenase, FAD-binding site
- FAD-dependent oxidoreductase 2, FAD-binding domain
- Succinate dehydrogenase, flavoprotein subunit
- Succinate dehydrogenase/fumarate reductase, flavoprotein subunit
- Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal
- Succinate dehydrogenase/fumarate reductase flavoprotein, catalytic domain superfamily
- FAD-dependent oxidoreductase SdhA/FrdA/AprA
- Fumarate reductase/succinate dehydrogenase flavoprotein-like, C-terminal domain superfamily
- FAD binding domain
- Fumarate reductase flavoprotein C-term
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SDHA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SDHA as an antibody target. Whether an autoantibody or antibody against SDHA could matter depends on whether native SDHA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SDHA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SDHA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...